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The Fall of Sleep K-Complex in 
Alzheimer Disease
Luigi De Gennaro1, Maurizio Gorgoni1, Flaminia Reda1, Giulia Lauri1, Ilaria Truglia1, 
Susanna Cordone1, Serena Scarpelli1, Anastasia Mangiaruga1, Aurora D’atri1, 
Giordano Lacidogna2, Michele Ferrara3, Camillo Marra2 & Paolo Maria Rossini2,4
Although a slowing of electroencephalographic (EEG) activity during wakefulness and –to some 
extent- sleep of Alzheimer disease (AD) patients (i.e., increased slow-frequency activity) was 
documented, recent findings in healthy elderly show a decreased 0.6–1 Hz slow wave activity (SWA) 
during NREM, which was associated to β-amyloid deposition and impaired hippocampal memory 
consolidation. We hypothesize that the apparent contradiction may be explained by the partial 
overlap between 0.6–1 Hz EEG activity and K-Complex (KC). According to this view, we studied both 
frontal KCs and SWA in 20 AD patients and 20 healthy age-matched controls (HC) during nightly sleep, 
under the hypothesis that KCs better discriminate patients from healthy elderly than ≤1 Hz SWA. A 
drastic decrease of KC density during stage 2 NREM was found in AD compared to HC. Patients show 
more than 40% reduction of the KC density, allowing a correct classification of 80%. On the other hand, 
≤1 Hz SWA of AD patients is slightly (not significantly) higher in most cortical areas compared to HC. 
Although no significant changes of ≤1 Hz SWA are detectable over frontal areas in AD, KC density 
decreases over the same location, and its decrease is related to the cognitive decline.
Alzheimer’s disease (AD) is characterized by several sleep alterations accompanying cognitive decline: the neural 
degeneration can induce per se alterations of sleep pattern and quality, which in turn may provoke a worsening 
of the cognitive decline, i.e. by the impairment of sleep-dependent memory consolidation processes1. The role of 
sleep as a factor which increases the rate of β -amyloid clearance2 raised a further interest in investigating specific 
sleep markers of AD.
The relatively consolidated electroencephalographic (EEG) signature of AD patients is represented by the 
phenomenon of “slowing”, a topographically diffuse slow-wave and theta activity characterizing wake and –to 
some extent- sleep EEG1,3,4.
Slow-wave activity (SWA)
The slowing of the EEG during wakefulness mostly affects frontotemporal areas5. During REM sleep, it appears as 
an increase of delta and theta power, which is larger in the temporoparietal and frontal regions6, while in NREM 
it is evidenced by a parietal decrease of sigma power7 and an increase of high (1.6–3.6 Hz) delta power8.
Apparently contradictory, a recent study showed in healthy subjects that the β -amyloid deposition is associ-
ated with an impaired frontal generation of NREM slow-wave activity (0.6–1 Hz) that, in turn, predicts hindered 
hippocampal memory consolidation9. The same group also demonstrated that age-related NREM slow-wave 
activity mediates the relation between prefrontal grey matter atrophy and impaired long-term memory and 
reduced hippocampal-prefrontal functional connectivity10. We hypothesize that these findings do not necessarily 
contradict the phenomenon of EEG slowing in AD patients, and that the < 1 Hz slow wave activity (SWA) may 
not correspond to delta waves but to another widespread event which occurs in NREM sleep, the K-complex 
(KC)11.
K-complexes (KCs)
KC is one of the hallmarks of NREM sleep and represents the EEG graphoelement with highest amplitude during 
normal sleep. KC was described more than 70 years ago and since then its physiology was evaluated in hundreds 
of studies (for a review12,). It is characterized by a short surface-positive transient followed by a slower, larger 
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surface-negative complex with peaks at 350 and 550 ms, then a final positivity peaking near 900 ms, all of them 
being generated in widespread cortical locations11. Several studies in cats and humans by Mircea Steriade demon-
strated that KCs have a < 1 Hz frequency13–15. KCs can be spontaneous, but sensory stimulation increases their 
probability in the ascending slopes of the sleep cycles to a higher degree than in the descending ones12. There is 
a close connection between the formation of KCs and phasic sensory activation12. At the same time, a relation 
between KC formation and the measure of sleep synchronization was observed16. The frequency of KCs decrease 
from cycle to cycle, parallel with the decrease in the depth of sleep17. It is assumed that the EEG phenomena of 
KCs during sleep arise under the effect of continuous sensory activation, hence they correspond to non specific 
evoked potential elements; therefore the KC can be regarded as a building stone of slow-wave sleep16, and has 
been considered a sort of ‘guardian’ for sleep protection.
Converging evidence in animals and humans points to a cortical origin of the KCs11,15,18,19, while the thalamus 
seems to have a role in mediating the cortically generated KCs15,20. KC is characterized by a frontal predomi-
nance12,21,22, and it shows a decrease in individual with alcohol use disorder, with a predominant effect at frontal 
brain regions23. Normal aging is associated with a decrease of spontaneous24,25 and evoked KCs26–28. This decrease 
is again more pronounced over the frontal cortex28. Preliminary observations also suggested that AD patients 
have a further reduction of spontaneous KCs29–31.
These converging pieces of evidence legitimate the hypothesis that the relation between decreased frontal 
0.6–1 Hz SWA and β -amyloid deposition, mechanistically contributing to the hippocampus-dependent cog-
nitive decline in the elderly9, might be – at least in part- explained by a reduced generation of spontaneous 
KCs. Therefore we hypothesize that: (A) KCs better discriminate AD patients from healthy elderly than slower 
(0.6–1 Hz) SWA, and (B) the reduced generation of spontaneous KCs in AD patients should correlate with the 
extent of cognitive decline, as measured by the Mini Mental State Examination (MMSE) scores.
Results
Demographic and clinical characteristics. Results of the t-tests performed on demographic and clinical 
characteristics of AD and healthy elderly control subjects (HC) are reported in Table 1. A significant between-
groups difference was observed for MMSE scores with higher scores in HC than in AD, and for State Trait Anxiety 
Index (STAI Y1 and STAI Y-2) with lower scores in HC than in AD. No significant difference was observed for 
age, education, Hamilton Depression Rating Scale (HDRS) and Pittsburgh Sleep Quality Index (PSQI).
Sleep measures. Table 2 reports the results of the t-tests performed on polysomnographic (PSG) measures. 
A significant difference was found for slow wave sleep (SWS), with a higher percentage of SWS in HC compared 
to AD. Moreover, a significant increase of Stage 1 and Stage 2 latency in AD compared to HC was observed.
As hypothesized, we found a strong reduction of KC density in AD compared to HC (t1,38 = 3.70, p = 0.0007) 
with a 42.7% decrease (Fig. 1). On the other hand, the between-group comparisons of ≤ 1 Hz SWA never reached 
significance at any scalp location (p > 0.10), although the general pattern suggests a relative slowing of EEG in 
AD, except for frontal sites (Fig. 2). This general pattern is confirmed when considering the proportion of ≤ 1 Hz 
SWA over the whole SWA (Fig. 3).
The discriminant analyses revealed KC density as the best classifier (F1,37 = 15.11; p = 0.0004), allowing a cor-
rect classification of 80%.
The relation between KCs and cognitive impairment. The multiple regression predicting MMSE 
scores on the basis of KC density and ≤ 1 Hz SWA was significant (rmultiple = 0.49; p = 0.02). The only significant 
predictor was KC density (β = 0.54; partial r = 0.50). Interestingly, the non significant partial correlation between 
≤ 1 Hz SWA and MMSE was negative (β = − 0.20; partial r = − 0.21). As expected, KC density and ≤ 1 Hz SWA 
were interrelated (r = 0.38; p = 0.02).
Control analysis on KCs regional differences. According to the main hypothesis of our study and to 
the evidence in normal aging24, the fall of spontaneous KCs should be more pronounced over the frontal cortex. 
To this aim, we also scored KCs over the available midline derivations (i.e., Cz and Pz). The mixed-design Group 
Variables
AD HC
t1,38 pMean (SE) Mean (SE)
Age (years) 72 (1.92) 70.35 (1.4) 0.69 0.49
Education (years) 9.65 (1.17) 11.60 (1.12) − 1.20 0.24
MMSE 16.40 (1.05) 28.75 (0.29) −11.32 <0.0001
HDRS 10.5 (1.24) 7.45 (1.09) 1.86 0.07
STAI Y-1 39.11 (2.19) 33.4 (1.41) 2.23 0.03
STAI Y-2 41.22 (2.02) 33.65 (1.92) 2.71 0.01
PSQI 5.10 (0.61) 6.05 (0.68) − 1.03 0.31
Table 1.  Mean and standard errors (SE) of demographic (age, education) and clinical (MMSE, HDRS, 
STAI Y-1, STAI Y-2, PSQI) characteristics of Alzheimer disease (AD) patients and healthy elderly controls 
(HC). MMSE, Mini Mental State Examination; HDRS, Hamilton Depression Rating Scale; STAI Y-1 and Y-2, 
State Trait Anxiety Index; PSQI, Pittsburgh Sleep Quality Index. The results of the statistical comparisons (t and 
p values) were also reported.
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(HC, AD) × Derivation (Fz, Cz, Pz) analysis of variance yielded a significant main effect for the Group factor 
(F1,38 = 13.42; p = 0.0007), with a lower KC density in AD (X = 0.36; SE = 0.04) than in HC (X = 0.59; SE = 0.05). 
The main effect for the Derivation factor was also significant (F2,76 = 61.67; p < 0.00000001), with a significant 
linear decrease from anterior to posterior sites (linear trend: F1,38 = 74.24; p < 0.00000001). Finally, the Group x 
Derivation interaction (Fig. 4) was significant (F2,76 = 6.24; p = 0.003), and it shows that the reduction in frontal 
KC activity was greater than that at the other brain regions (Fz = 42.7%, Cz = 36.0%; Pz = 35.4%).
Discussion
Our results show a striking decrease of frontal spontaneous KC density during NREM sleep in AD patients com-
pared to HC. The reduction of KC density over the frontal area of AD patients exceeds 40%. On the other hand, 
SWA on the same frontal site is not significantly different between groups. In contrast to SWA, KC density was 
also positively related with MMSE scores.
In agreement with previous PSG studies1, sleep of our AD patients is characterized by a decrease of SWS 
and a lengthening of sleep latency. However, the quantitative EEG analysis points to a more articulated regional 
pattern. The general tendency of AD patients to present a higher ≤ 1 Hz SWA compared to HC appears counter-
balanced over the frontal areas by a relative decrease of KCs. In fact, our control analysis shows that the reduction 
of KCs is larger over the frontal site, and it diminishes progressively along the antero-posterior axis. Therefore, 
the overall tendency of SWA to increase in AD is obscured on the cortical area where the drop of KCs is more 
pronounced. According to this interpretation, the empirical finding in healthy elderly people of an association 
between the β -amyloid burden and SWA9,10 could be hardly replicated in AD patients, due to the dissociation 
between increased SWA and decreased KC density.
Variables
AD HC
t1,38 pMean (SE) Mean (SE)
Stage 1 latency 
(min) 51.02 (13.43) 21.45 (4.96) 2.07 0.05
Stage 2 latency 
(min) 42.88 (13.21) 14.15 (3.79) 2.09 0.04
Stage 1 (%) 11.59 (2.39) 6.71 (1.04) 1.87 0.07
Stage 2 (%) 74.90 (2.65) 76.76 (1.78) − 0.58 0.56
SWS (%) 0.14 (0.07) 0.95 (0.37) −2.11 0.04
REM (%) 13.58 (2.54) 15.93 (1.28) − 0.83 0.41
WASO (min) 86.38 (11.37) 83.86 (8.24) 0.18 0.86
Awakenings (#) 17.25 (3.05) 20.30 (1.81) − 0.86 0.4
Arousals (#) 35.70 (7.41) 32.25 (6.09) 0.36 0.72
TST (min) 260.67 (18.74) 300.12 (14.88) − 1.65 0.11
TBT (min) 389.07 (16.79) 397.18 (11.97) − 0.39 0.70
SEI % (TST/
TBT) 66.74 (3.66) 75.23 (2.68) − 1.87 0.07
Table 2.  Mean and standard errors (SE) of the polysomnographic variables of Alzheimer disease (AD) 
patients and healthy elderly controls (HC). The results of the statistical comparisons (t and p values) are 
included. SWS, slow-wave sleep; REM, rapid eye movement; WASO, wake after sleep onset; TST, total sleep 
time; TBT, total bed time; SEI, sleep efficiency index.
Figure 1. Absolute values and mean of K-Complex (KC) density of Alzheimer’s Disease (AD) patients and 
healthy controls (HC) at Fz cortical derivation. 
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Figure 2. Topographical scalp maps of 0.6–1 Hz (≤1 Hz) slow-wave activity (SWA) in AD patients and HC. 
The maps are based on the 19 derivations of the 10–20 system (electrodes positions indicated by black dots). 
Values are color-coded and plotted at the corresponding position on the planar projection of the hemispheric 
scalp model. Values between electrodes were interpolated (biharmonic spline interpolation). Values are 
expressed in terms of log values of ≤ 1 Hz SWA during NREM sleep of the two groups (left side) and values of 
the between group comparisons (t-test values on the right side).
Figure 3. Topographical scalp maps of the ratio between 0.6–1 Hz ( ≤1 Hz) activity and the whole 
(0.6–4 Hz) slow-wave activity (SWA) in AD patients and HC. The maps are based on the 19 derivations of 
the 10–20 system (electrodes positions indicated by black dots). Values are color-coded and plotted at the 
corresponding position on the planar projection of the hemispheric scalp model. Values between electrodes 
were interpolated (biharmonic spline interpolation). Values are expressed in terms of ratio between 0.6–
1/0.6–4 Hz EEG activity during NREM sleep of the two groups (left side) and values of the between group 
comparisons (t-test values on the right side).
Figure 4. Means and standard errors of KC density in Alzheimer’s Disease (AD) patients and healthy 
controls (HC) recorded over midline derivations (Fz, Cz, and Pz). 
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A similar dissociation was reported during SWS in demented patients compared to normal elderly8. Albeit the 
relatively small sample size (but still the largest in the literature) and the heterogeneity of the dementia group, this 
study reported a decreased amplitude and incidence of slow delta waves (< 1.6 Hz) and an increased incidence 
of fast delta waves (2–3.6 Hz). Since KCs mostly correspond to slow delta frequency events and some evidence 
suggests that they may be considered as single instances of delta EEG activity that predominates in SWS16,18,32, the 
observation by Bonanni and coworkers8 is coherent with the decreased incidence of KCs in dementia.
In our opinion, the dissociation between KCs and SWA depends on the cortical origin of the former. The 
cortical origin of KCs is supported by several studies11,15,19, and their generation seems associated with cortical 
slow (< 1 Hz) oscillations15. Since glial cells seem to have a significant role in producing slow oscillations33, glial 
alterations were proposed as possible neural basis for the impaired cortical ability to produce KCs34. Alternatively, 
AD-related damage at the level of the cholinergic basal forebrain35,36 may account for KCs alterations34, in line 
with a model of KCs generation proposed by Colrain and Crowley37, which involves the connection between the 
brainstem reticular activating system, the basal forebrain and the cortex. In any case, four different phenomena 
are at work in AD patients: (1) the drop of KCs, more pronounced over the frontal areas; (2) a lack of differences 
over the same frontal areas in ≤ 1 Hz EEG activity; (3) a general slowing of EEG activity (not significant probably 
due to the relatively small sample size); and (4) the decrease of visually scored SWS (paralleled by a lengthening 
of sleep latency). While the last effect is likely an expression of a worse sleep quality, the others have a different 
origin.
Beyond extending the preliminary evidence of KC alterations in AD patients31,34, we also show that the drastic 
decrease of KCs is related to the cognitive impairment. This relation may give some hints about the functional 
significance of the KC density decrease in AD patients. Results from Cash and co-workers11 show that KCs are 
generated in widespread cortical areas and are accompanied by a decrease in cortical activity, representing iso-
lated cortical down-states. Sleep-related cortical down-states are thought to be associated with a reduction of 
synaptic strength that should counterbalance the wake-related synaptic enhancement, and this mechanism seems 
to be strongly related with memory processes and brain cellular energy regulation38. In this view, the reduced 
ability to produce KCs in AD patients may be associated to a disruption of sleep-related memory processes, 
contributing to the cognitive deterioration in these patients. The relation mutually linking impaired long-term 
memory and reduced hippocampal-prefrontal functional connectivity and age-related prefrontal grey matter 
atrophy and lower slow-wave activity, respectively9,10, goes in the same direction. Hence, our finding further 
supports the notion of a bidirectional influence between sleep alterations and cognitive deterioration in AD: the 
neurodegenerative process affect the hypnic profile and pattern (i.e. reduction of KCs density), which in turn 
provokes a further deterioration of the cognitive status presumably by negatively impacting on synaptic plasticity 
and memory consolidation processes.
From a clinical point of view, the present findings provide further evidence about the relation between sleep 
alteration and cognitive functioning in AD, endorsing sleep improvement as a possible strategy to reduce the 
AD-related cognitive deterioration process and disease progression rate. To this aim, recent studies enhancing 
slow oscillations in humans by means of electrical39–41, transcranial magnetic42 and acoustic43–47 stimulation 
appear promising. Notably, the boost of slow oscillation during sleep was also associated with beneficial effects 
on memory processes39–41,43.
Limitations to the study. The main limitation of the present study is that our results intrinsically do not 
allow establishing any causal relation among the several phenomena observed in NREM sleep of AD patients (i.e., 
the frontal fall of KCs, the absence of differences in the 0.6–1 Hz in the frontal region, the general -not significant- 
slowing of EEG activity, and the decrease of SWS).
As a second limitation, it must be considered that the beginning of the sleep EEG recordings was fixed at a 
specific bedtime (23.00) for all subjects. Given the observation that AD patients often exhibit circadian misalign-
ment, it could be argued that a fixed bedtime may have influenced our findings, since we compare AD patients 
with a group of HC theoretically circadian aligned. However, it is worth noting that the evaluation of a regular 
sleep-wake cycle was one of the inclusion criteria for the present study (see the ‘Inclusion and exclusion criteria’ 
section), and this may partially face the issue of a possible circadian bias.
Finally, our study does not evaluate the CAP A1 phase48. This is a phasic slow wave event which starts with 
KC-like huge biphasic slow components. It consists of periods of KC and delta bursts, polyphasic bursts, vertex 
sharp transients, with < 20% of EEG desynchrony. Part of this phasic event may fit into 0.6–1 Hz range, and it 
would be interesting, in the future, to specifically investigate this issue.
Conclusions
Sleep may represent a still unexplored, but privileged window on the neurophysiological changes of AD. Our 
finding suggests that the association in healthy older people between impaired long-term memory, age-related 
prefrontal grey matter atrophy, β -amyloid plaques burden, and slow-wave activity in the EEG of NREM sleep9 
cannot be extended to AD patients. The hypothesized increase of ≤ 1 Hz EEG activity characterizing SWA dur-
ing NREM sleep is masked by a concomitant (and larger) change of opposite sign. KC, as a phasic slow wave 
of NREM sleep, is indeed significantly less frequent over frontal areas in AD, and its decrease is related to the 
cognitive decline as measured by MMSE scores. This also confirms other studies pointing to an involvement of 
frontal areas in the neurodegenerative process49. Future studies should directly investigate the neural basis and 
the functional role of the AD-related KC decrease by assessing its relation with grey matter atrophy and the dep-
osition of β -amyloid. Above all, these relations should be evaluated by prospective studies aimed at investigating 
the longitudinal association between KC density reduction, cognitive decline, and neuroanatomical changes.
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Methods
Subjects. In the present study, 20 AD patients (7 males and 13 females; mean age = 72.0 yrs.) and 20 HC 
(12 males and 8 females; mean age = 70.3 yrs.) were recruited. Demographic and clinical characteristics of the 
recruited sample populations are reported in Table 1. Patients were enrolled for the study just after their diag-
nosis [8 mild AD (MMSE score = 18–23); 8 moderate AD (MMSE score = 13–17); 4 severe AD (MMSE score 
< 13)]. Patients were selected among the elderly persons referred to the Neuropsychology Unit of the Gemelli 
Foundation, Catholic University Hospital of Rome. HC were recruited in clubs for retired people. All subjects gave 
their written informed consent. The study was approved by the Institutional Review Board of the Department 
of Psychology of the University of Rome “Sapienza” and by the Institutional Ethical Committee of the Catholic 
University Hospital of Rome, and was conducted in accordance with the Declaration of Helsinki.
Inclusion and exclusion criteria. All participants underwent cognitive screening by means of the Mini 
Mental State Examination (MMSE)50. Moreover, the State Trait Anxiety Index (STAI-Y1 and STAI-Y2)51 and the 
HDRS52 were administered in order to exclude major psychiatric illness.
Neuropsychological investigation for AD patients included a structured clinical evaluation, brain neuro-
imaging (MRI or CT), and a neuropsychological test battery for the assessment of specific cognitive functions 
such as memory, attention, executive function, visuo-construction abilities and language. In particular, memory 
assessment included Rey’s Auditory Verbal Learning (RAVLT)53, involving immediate recall (RAVLTir = 14.8; 
SE = 1.8), delayed recall (RAVLTdr = 0.6; SE = 0.3) and delayed recognition (Accuracy of RAVLTrec = 74%; 
SE = 4.6%), delayed recall of the Rey figures54, delayed recall of a three-word list55 and delayed recall of a story56,57. 
The functional status was assessed by the Activities of Daily Living (ADL = 5.33; SE = 0.3) and Instrumental 
Activities of Daily Living (IADL) questionnaire58. AD patients were included according to the National Institute 
on Aging-Alzheimer’s Association workgroups59 and DSM-IV criteria.
Common exclusion criteria for all participants were: presence of neurological, psychiatric or vascular dis-
orders, obesity, history of alcoholism, drug abuse and hypnotic intake. HC receiving psychoactive drugs were 
also excluded. The final enrollment in the study was based on the evaluation of regular sleep-wake cycle and 
on the absence of self-rated sleep disorders. The presence of other sleep disorders was objectively evaluated by 
nocturnal sleep recordings. In case of sleep disorder and/or respiratory diseases and obstructive sleep apnea syn-
drome (OSAS), subjects were excluded by subsequent analyses. Sleep quality and diurnal sleepiness of all partic-
ipants were assessed by the Italian version of the PSQI60, the Epworth Sleepiness Scale (ESS)61 and the Karolinska 
Sleepiness Scale (KSS)62.
Study design and experimental schedule. Participants underwent a complete polysomnographic (PSG) 
recording of a nocturnal sleep at the Catholic University Hospital of Rome. The sleep-wake history of HC in 
the day preceding the study was controlled by a sleep diary and -as far as possible- by hospital staff for the AD 
patients. Naps were not allowed, although compliance was not objectively controlled (i.e., by actigraphic record-
ings) to have daily naps.
Participants arrived in the sleep laboratory around 20.00 (HC from their home and AD patients from the hos-
pital ward, accompanied by their caregivers). After PSG montage, they were requested to fill in the PSQI, ESS, and 
KSS. Caregivers were asked when patients were not able to respond. Then, resting EEG was recorded for a 5-min 
eyes-closed period, followed by a 5-min eyes-open period (data not reported here). Sleep recordings started at 
23.00. If not already awake, participants were awakened at 6.00. Before leaving the sleep laboratory, their resting 
EEG was again recorded (5-min eyes-closed and 5-min eyes-open periods).
Polysomnographic recordings. A Micromed system plus digital polygraph was used for the PSG record-
ing. EEG signals were acquired with a sampling frequency of 256 Hz and band-pass filtered at 0.53–40 Hz. The 19 
unipolar EEG derivations of the international 10–20 system (C3, C4, Cz, F1, F2, F3, F4, F7, F8, Fz, O1, O2, P3, 
P4, Pz, T3, T4, T5, T6) were recorded from scalp electrodes with average mastoid references (A1 and A2), using 
Ag/AgCl electrodes. Electrooculogram (EOG) was recorded from electrodes placed about 1 cm from the medial 
and lateral canthi of the dominant eye. Electrocardiogram (EKG) and submental electromyogram (EMG) were 
also recorded. Finally, a pulse oximeter was placed on the right index finger with the aim to exclude sleep respira-
tory disorders. Periodic Limb Movements were not measured by a tibialis EMG recording, but excluded on the 
basis the PSQI evaluation and their clinical history. Any contamination of EEG recordings by muscle activity was 
however excluded by subsequent analyses. Impedance was kept below 5 KOhm.
Data Analysis
Demographics and clinical characteristics. Age, years of education and clinical characteristics (MMSE, 
HDRS, STAI Y-1, STAI Y-2 and PSQI scores) of AD and HC were compared by two-tailed t-tests for independent 
samples. Alpha level was always set at 0.05.
Sleep measures. Sleep stages of the baseline night were scored visually in 20 seconds epochs, according to 
standard criteria63, excluding ocular and muscle artifacts. The following were considered as dependent variables: 
(a) stage 1 latency; (b) stage 2 latency; (c) total sleep time (TST), defined as the sum of time spent in stage 1, stage 2, 
SWS and REM; (d) percentage of each sleep stage (time spent in a sleep stage/TST × 100); (e) wakefulness after 
sleep onset (WASO), in minutes; (f) number of awakenings; (g) number of arousals; (h) total bed time (TBT); 
(i) sleep efficiency index (SEI = TST/TBT × 100). An awakening was scored whenever an EEG/EMG activation 
occurred lasting more than 10 s. Arousals were scored whenever an EMG activation affected the EEG recording 
for periods shorter than 10 s.
The polysomnographic EEG measures were compared by two-tailed t-tests for independent samples.
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KC detection. Spontaneous KCs were visually identified by a blind scorer during NREM stage 2 sleep on Fz. 
To score a KC, the following criteria were applied: a nonstationary event with (a) a marked and well-delineated 
sharp wave initially negative in polarity, immediately followed by a positive polarity component; (b) maxi-
mum amplitude at frontocentral derivations; (c) a minimum duration of 0.5 s and a maximum duration of 3 s. 
According to Crowley and coworkers28, no amplitude criterion was applied in the present study, since the previ-
ously observed amplitude decrease in older subjects29. If multiple KCs appeared in sequence, only the first one 
was considered64. KC density was calculated as the number of KCs divided by NREM stage 2 sleep minutes.
Measure of slow-wave activity. The polygraphic signals (19 EEG channels, EOG and EMG) were analog 
to digital converted on-line with a sampling rate of 256 Hz and bandpass filtered at 0.53–40 Hz. Ocular and mus-
cle artefacts were excluded off-line by visual inspection. We calculated power spectra for the SWA of NREM sleep 
within the 0.6–4 Hz range by a Fast Fourier Transform routine for 4 s periodograms. Aimed to match sleep scor-
ing, power spectra were averaged over 5 consecutive 4-sec epochs to yield a 20-s spectrum. Power spectra were 
calculated for NREM stages (stage 2 + 3 + 4).
EEG power values for the ≤ 1 Hz SWA, computed within the 0.6–1 Hz range, were the main dependent meas-
ure. Values were log-transformed, colour coded, plotted at the corresponding position on the planar projection of 
the scalp surface, and interpolated (biharmonic spline) between electrodes. According to Mander and coworkers9, 
≤ 1 Hz SWA was also expressed as the ratio between 0.6–1/0.6–4 Hz EEG activity (i.e., ≤ 1 Hz/SWA).
Statistical analysis. Group difference in KC density was assessed by means of two-tailed t-tests comparing 
AD and HC. Preliminary analyses also considered Gender as a between factor, without any significant main effect 
or interaction involving this factor. For this reason, it was collapsed in the subsequent analyses. Similarly, ≤ 1 Hz 
frontal SWA and the proportion of ≤ 1 Hz SWA/SWA were compared between groups. A discriminant analysis 
was also performed considering KC density and ≤ 1 Hz frontal SWA as discriminant measures.
Finally, in order to assess the relationship between KCs and cognitive impairment, a multiple regression was 
computed between Age, KC density and ≤ 1 Hz frontal SWA, as independent measures, and MMSE scores, as 
dependent measure.
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